A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans
- 31 December 1991
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes
- Vol. 42 (5) , 435-439
- https://doi.org/10.1016/0883-2889(91)90102-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Kinetics and displacements of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomographyPublished by Elsevier ,2002
- Metabolism of the benzodiazepine antagonist11C-Ro 15-1788 after intravenous administration in manHuman Psychopharmacology: Clinical and Experimental, 1989
- 11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptorsInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988
- Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PETJournal of Cerebral Blood Flow & Metabolism, 1988
- In vivo binding of (3H) Ro 15-1788 in mice: Comparison with the in vivo binding of (3H) flunitrazepamLife Sciences, 1988
- Imaging of [11C]-labelled RO 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomographyJournal of Psychiatric Research, 1985
- Synthesis of ethyl 8-fluoro-5,6-dihydro5- [11C]methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): A specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomographyThe International Journal of Applied Radiation and Isotopes, 1984